[ORGANIZATION]
Amsterdam UMC
Featured in 10 tracked stories · first seen
Situations
Expanding therapeutic uses and regulatory approvals for GLP-
34 clusters · 155 sources · last updated
Latest: Semaglutide linked to reduced psychiatric hospitalizations
Medical research continues to expand the therapeutic potential of GLP-1 receptor agonists like semaglutide and tirzepatide. While semaglutide is widely used for weight loss and diabetes, new evidence suggests it may slow
Cholesterol levels and awareness in Germany
2 clusters · 10 sources · last updated
Latest: Germany faces significant gaps in LDL cholesterol awareness
Data from the Robert Koch Institute indicates that approximately 58 percent of the German population has elevated cholesterol levels. High cholesterol, particularly LDL, is noted as a contributor to atherosclerosis, whic
Also covered in
-
Westknollendam: Boy seriously injured during scooter gathering
[CRIME] · 3 sources ·
-
Rotterdam calls for Food Act amid high unhealthy food availability
[HEALTH] · 2 sources ·
-
Patras hosts scientific seminar on cancer research and immunotherapy
[HEALTH] · 2 sources ·
-
Dutch academics face mental health crisis, study finds
[HEALTH] · 2 sources ·
-
Diabetes mechanisms differ in lean African populations
[HEALTH] · 3 sources ·
-
Amsterdam UMC study finds blood pressure drug may slow rare childhood brain disease
[HEALTH] · 6 sources ·